• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Did Johnson & Johnson Just Spit in Alphabet's Face?

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Feb 14, 2019 at 10:22: AM
via If you had any doubts whether or not Johnson & Johnson (NYSE: JNJ) is serious about robotic surgery, you now have your answer. The healthcare giant announced on Wednesday that it plans to acquire privately held robotic surgery company Auris Health for $3.4 billion.

article source
 




Top Bottom
Back
Quote